Immunotherapy refers to a type of non-fully differentiated cell, which exists in early stage of embryo, marrow, umbilical cord, placenta and part of cells of adult people. Immunotherapy can be cultivated to muscle, bone, nerve and various human tissues and organs. It is regarded of consequence by the scientists to treat cancer and other various malignant diseases with tissues and organs cultivated from Immunotherapy, which has bring more hope to the patients with diabetes, senile dementia, parkinson’s disease and patients with spinal cord impairment. In recent years, researches on Immunotherapy have become the hotspot of the biomedicine community. From 90s of 20th century, the technology of hemopoietic Immunotherapyation has been at full speed of development. And this technology is safer and more effective, which has cured various benign or malignant blood diseases and has become one of the important methods to treat genetic diseases.
The recent development and significance of Immunotherapy
If we ask what the most noticeable science is in 21th century, undoubtedly,
it is life science. It has been asserted by scientists in last century that the
21th century is the century of life science. Indeed, with the development of
human science, more and more secrets of life have been revealed. And in the
research of life science, a research direction has represented the most cutting
edge, this is the research on Immunotherapy.
The significance of research on Immunotherapy
There are various superiorities of treatment of Immunotherapy: low toxicity
or non toxicity, which means that this treatment can achieve good effects even
the exact mechanisms of the diseases are not completely known. Autologous
Immunotherapyation can avoid the generation of immunological rejection, and this
method has amazing effects on those diseases on which traditional treatment
methods have no good effects. With the development of research on embryonic
Immunotherapy (ESC) and intrusion prevention system (IPS), there are more
possibility to obtain the totipotent Immunotherapy from the cells of the
patients and then differentiate into the needed cells and even organs. So it is
not only a dream to obtain the cells and organs without any immunological
rejection. And when our human organs begin to grow old, we may replace the old
organs with the new organs cultivated from our Immunotherapy, by which we can
achieve the goal of prolonging life for the human beings.
The recent developments of Immunotherapy.
At present, there are more and more scientists throwing themselves to the
researches on the clinical application of Immunotherapy. There are more than
2100 registered project of researches on treating diseases with Immunotherapy.
Especially in the recent years (from 2005), the number of projects on
Immunotherapy rises sharply. And in January, 2009, the Geron company of America
has obtain the authorization of the FDA to research on treating diseases with
the cells differentiated from the human embryonic Immunotherapy (ECS).
And in china, recent years, the Immunotherapy research has become the most
demanded field. From 1998 to 2009, more than 2000 pieces of papers have been
published, which can indicate that more and more importance have been attached
to the research on Immunotherapy, and the technology level has been improved
greatly. And the ministry of science and technology of china has established
significant special project to support the research on Immunotherapy.
In may f 2005, the first practice of using neural Immunotherapy to treat the
child patient with cerebral palsy has been operated in the Immunotherapy center
of Sanmenxia City Hospital. And this practice has broken the traditional thought
that neonate cerebral palsy is not curable. And this is the first case in the
world, which has indicate that the research and technology on Immunotherapy have
paced into the first class in the world.